The neuroleptic malignant syndrome: a logical approach to the patient with temperature and rigidity.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 9616487.
- Also identified by PMC identifier 2360818.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The neuroleptic malignant syndrome is a rare, potentially fatal, adverse reaction to neuroleptic drugs characterised by severe rigidity, high temperature and autonomic dysfunction. In the light of the hypothesized pathophysiology of this condition, a rational approach to the management of patients presenting with temperature and rigidity is provided. The aims of this approach are three-fold: to reduce the incidence of the condition, to be able to recognise it early so as to treat before life-threatening complications arise, and to be able to recognise early those conditions which mimic neuroleptic malignant syndrome, so as not to delay their specific treatment.
Medical subject headings
- Critical Care
- Neuroleptic Malignant Syndrome